Professional background

Dr Windsor is a paediatrician with a sub-specialist interest in oncology. She works within the Children and Young People’s Cancer Service at UCLH, specialising in the treatment of children and young people with bone and soft tissue sarcoma. She completed her MD Res in the pharmacogenomics of osteosarcoma chemotherapy and is actively involved in an ongoing international collaboration. Her other clinical interest is long term effects of cancer treatment and she am one of the core clinicians within the UCLH Late Effects Service.

Research interests

Dr Windsor is a working group member of PanCare, a pan-European network that aims to reduce the frequency, severity and impact of late side effects of the treatment of children and adolescents with cancer. She is also the Chair of the Teenagers and Young Adults with Cancer (TYAC) Professional Education Subgroup and a member of the NCRI TYA CSG Biological Studies Subgroup.

Publications

Mulder RL, van der Pal HJ, Levitt GA, Skinner R, Kremer LC, Brown MC, Bárdi E, Windsor R, Michel G, Frey E. Transition guidelines: An important step in the future care for childhood cancer survivors. A comprehensive definition as groundwork. Eur J Cancer 2016; 54:64-8

Treatment of Cancer 6th Edition 2014 Sikora K, Price P. Primary Bone Tumours. Cassoni A, Pollock R, Windsor R, Whelan J.

Windsor R, Strauss SJ, Kallis C, Wood N, Whelan J. Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study. Cancer 2012 Apr 1; 118(7): 1856-67

Windsor R, Strauss SJ, Seddon B, Whelan J.  Experimental Therapies in Ewing's Sarcoma. Expert Opinion On Investigational Drugs 2009; 18(2): 143-159

Windsor R, Stiller C, Webb D. Peripheral T-cell Lymphoma in Childhood- Population Based Experience in the United Kingdom over 20 years. Pediatric Blood and Cancer 2008 Apr; 50(4): 784-7

GMC/GDC number: 4094111